Kaken Pharmaceutical Statistics
Total Valuation
KKPCF has a market cap or net worth of 1.06 billion. The enterprise value is 538.48 million.
| Market Cap | 1.06B |
| Enterprise Value | 538.48M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 32.67M |
Valuation Ratios
The trailing PE ratio is 8.12.
| PE Ratio | 8.12 |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.12 |
| EV / Sales | 0.84 |
| EV / EBITDA | n/a |
| EV / EBIT | 3.00 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.38 |
| Quick Ratio | 3.75 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 1,133.26 |
Financial Efficiency
Return on equity (ROE) is 13.90% and return on invested capital (ROIC) is 10.75%.
| Return on Equity (ROE) | 13.90% |
| Return on Assets (ROA) | 9.01% |
| Return on Invested Capital (ROIC) | 10.75% |
| Return on Capital Employed (ROCE) | 15.87% |
| Revenue Per Employee | 523,126 |
| Profits Per Employee | 115,022 |
| Employee Count | 1,135 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.09% in the last 52 weeks. The beta is 0.14, so KKPCF's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +20.09% |
| 50-Day Moving Average | 26.54 |
| 200-Day Moving Average | 26.66 |
| Relative Strength Index (RSI) | 97.49 |
| Average Volume (20 Days) | 60 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KKPCF had revenue of 593.75 million and earned 130.55 million in profits. Earnings per share was 3.45.
| Revenue | 593.75M |
| Gross Profit | 368.10M |
| Operating Income | 165.79M |
| Pretax Income | 169.17M |
| Net Income | 130.55M |
| EBITDA | n/a |
| EBIT | 165.79M |
| Earnings Per Share (EPS) | 3.45 |
Balance Sheet
The company has 507.27 million in cash and 24.49 million in debt, giving a net cash position of 482.78 million.
| Cash & Cash Equivalents | 507.27M |
| Total Debt | 24.49M |
| Net Cash | 482.78M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 987.51M |
| Book Value Per Share | 26.07 |
| Working Capital | 628.83M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.00%, with operating and profit margins of 27.92% and 21.99%.
| Gross Margin | 62.00% |
| Operating Margin | 27.92% |
| Pretax Margin | 28.49% |
| Profit Margin | 21.99% |
| EBITDA Margin | n/a |
| EBIT Margin | 27.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 4.87%.
| Dividend Per Share | 1.30 |
| Dividend Yield | 4.87% |
| Dividend Growth (YoY) | 30.75% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.62% |
| Shareholder Yield | 4.25% |
| Earnings Yield | 12.31% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KKPCF has an Altman Z-Score of 4.82.
| Altman Z-Score | 4.82 |
| Piotroski F-Score | n/a |